Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Bangs C"'
Autor:
Shillitoe, B.1,2,3, Bangs, C.1,4, Guzman, D.1,5, Gennery, A. R.1,2,3, Longhurst, H. J.6, Slatter, M.2,3, Edgar, D. M.7, Thomas, M.8, Worth, A.1,9, Huissoon, A.10, Arkwright, P. D.4, Jolles, S.11, Bourne, H.12, Alachkar, H.13, Savic, S.14, Kumararatne, D. S.6, Patel, S.15, Baxendale, H.16, Noorani, S.17, Yong, P. F. K.18
Publikováno v:
Clinical & Experimental Immunology. Jun2018, Vol. 192 Issue 3, p284-291. 9p. 3 Charts, 3 Graphs, 1 Map.
Autor:
Stubbs, A.1, Bangs, C.1,2, Shillitoe, B.3, Edgar, J. D.2,4, Burns, S. O.5, Thomas, M.6, Alachkar, H.7, Buckland, M.2,8, McDermott, E.9, Arumugakani, G.10, Jolles, M. S.11, Herriot, R.12, Arkwright, P. D.1 peter.arkwright@nhs.net
Publikováno v:
Clinical & Experimental Immunology. Feb2018, Vol. 191 Issue 2, p212-219. 8p. 3 Charts, 2 Graphs.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maccari, M.E., Abolhassani, H., Aghamohammadi, A., Aiuti, A., Aleinikova, O., Bangs, C., Baris, S., Barzaghi, F., Baxendale, H., Buckland, M., Burns, S.O., Cancrini, C., Cant, A., Cathebras, P., Cavazzana, M., Chandra, A., Conti, F., Coulter, T., Devlin, L.A., Edgar, J.D.M., Faust, S., Fischer, A., Prat, M.G., Hammarstrom, L., Heeg, M., Jolles, S., Karakoc-Aydiner, E., Kindle, G., Kiykim, A., Kumararatne, D., Grimbacher, B., Longhurst, H., Mahlaoui, N., Milota, T., Moreira, F., Moshous, D., Mukhina, A., Neth, O., Neven, B., Nieters, A., Olbrich, P., Ozen, A., Schmid, J.P., Picard, C., Prader, S., Rae, W., Reichenbach, J., Rusch, S., Savic, S., Scarselli, A., Scheible, R., Sediva, A., Sharapova, S.O., Shcherbina, A., Slatter, M., Soler-Palacin, P., Stanislas, A., Suarez, F., Tucci, F., Uhlmann, A., van Montfrans, J., Warnatz, K., Williams, A.P., Wood, P., Kracker, S., Condliffe, A.M., Ehl, S.
Activated phosphoinositide 3-kinase (PI3K) δ Syndrome (APDS), caused by autosomal\ud dominant mutations in PIK3CD (APDS1) or PIK3R1 (APDS2), is a heterogeneous primary\ud immunodeficiency. While initial cohort-descriptions summarized the spectrum of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::9225d0cbcc12c4749f73c56bb7637be5
https://eprints.whiterose.ac.uk/129346/1/maccarifimmu-09-00543-1.pdf
https://eprints.whiterose.ac.uk/129346/1/maccarifimmu-09-00543-1.pdf
Autor:
Caballero, T., Aberer, W., Longhurst, H.J., Maurer, M., Zanichelli, A., Perrin, A., Bouillet, L., Andresen, I., Arcoleo, F., Bova, M., Cicardi, M., Cillari, E., Montinaro, V., Marone, G., Blanchard Delauny, C., Boccon‐Gibod, I., Coppere, B., Dzviga, C., Fain, O., Goichot, B., Gompel, A., Guez, S., Jeandel, P.Y., Kanny, G., Launay, D., Maillard, H., Martin, L., Masseau, A., Ollivier, Y., Magerl, M., Baeza, M.L., Cabañas, R., Guilarte, M., Hernández, D., Hernando de Larramendi, C., Lleonart, R., Lobera, T., Marqués, L., Bangs, C., Buckland, M., Grigoriadou, S., Helbert, M., Lorenzo, L.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Background Hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) is a rare, potentially fatal, bradykinin-mediated disease. Icatibant is a bradykinin B2 receptor antagonist originally approved in 2008 in the European Union and 2011
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab80520f2ce9abcbedb798b9d27f0e1b
http://hdl.handle.net/11588/702401
http://hdl.handle.net/11588/702401
Publikováno v:
Vox Sanguinis. Apr2016, Vol. 110 Issue 3, p282-284. 3p. 2 Charts.
Autor:
Gathmann B., Binder N., Ehl S., Kindle G., Mahlaoui N., Devergnes N., Brosselin P., Sanal O., Yegin O., Kutukculer N., Kilic S. S., Barlan I. B., Reisly I., Caracseghi F., Santos J. L., Llobet P., Carbone J., Granado L. I. G., Sanchez Ramon S., Tricas L., Matamoros N., Exley A., Kumaratne D., Alwood Z., Grimbacher B., Longhurst H., Knerr V., Bangs C., Boardman B., Tierney P., Chapel H., Notarangelo L. D., Plebani A., PIGNATA, CLAUDIO, Nickel R., Schauer U., Spath B., Caiser P., Roisler J., Bieneman K., Line R., Schubert R., El Helou S., Ritterbusch H., Goldacker S., Duckers G., Fabhauer M., Borte M., Notheis G., Belohradsky B. H., Sollinger F., Classen C. F., Apel K., Steinmann S., Muglich C., Szaflarska A., Bernatowska E., Heropolitansca E., Kuijpers T. W., van Beem R., Galal N. M., Reda S., Farber C. L., Meyts I., Velbri S., Kanariou M., Farmaki E., Papadopoulou Alataki E., Trachana M., Richter D., Blaziene A., Seidel M., Marques L., Feighery C., Cucuruz M., Konoplyannikova J., Paschenko O., Shcherbina A., Berglof A., Jardefors H., Wargstrom P., Brodszki N., Cantoni N., Dupenthaler A., Fahrni G., Hoernes M., Sahbacher U., Pasic S., Ciznar P., Jeverica A. K., Litzman J., Hlavackova E., Savchak I., Farkas H., Marodi L.
In order to build a common data pool and estimate the disease burden of primary immunodeficiencies (PID) in Europe, the European Society for Immunodeficiencies (ESID) has developed an internet-based database for clinical and research data on patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::fb433d2a6b74d41a4ba5638274f5db59
http://hdl.handle.net/11588/461322
http://hdl.handle.net/11588/461322
Autor:
Gathmann B., Grimbacher B., Beauté J., Dudoit Y., Mahlaoui N., Fischer A., Knerr V., Kindle G., Micol R., Benslama L., Plebani A., Notarangelo L., PIGNATA, CLAUDIO, Bangs C., Lucas M., Tierney P., Core C., Dempster J., Exley A., Kumararatne D., Paschenko O., Kondratenko I., Shcherbina A., Velbri S., Ciznar P., Duobiene R., Kilic S., Kütükcüler N., Sanal O., Reisli I., Yegin O., Kanariou M., Papadopoulou Alataki E., Trachana M., Hatzistilianou M., Farber C.M., Meyts I., Pasic S., Richter D., Marodi L., Touitou I., Abuzakouk M., Feighery C., Thon V., Litzman J., Cucuruz M., Wolska B., Szaflarska A., Reda S., Soler P., Caragol I., Llobet P., Savchak I., Marques L., Koren A., Hörnes M., Shchebet S., Goldacker S., Ritterbusch H., Fasshauer M., Sollinger F., Witte T., Baumann U., Wittkowski H., Viemann D., Niehues T., Stimm H., Brodszki N.
Publikováno v:
Clinical and Experimental Immunology
Clinical and Experimental Immunology, Wiley, 2009, 157 (suppl 1), pp.3-11. ⟨10.1111/j.1365-2249.2009.03954.x⟩
Clinical and Experimental Immunology, Wiley, 2009, 157 (suppl 1), pp.3-11. ⟨10.1111/j.1365-2249.2009.03954.x⟩
Summary Primary immunodeficiencies (PID) are rare diseases; therefore transnational studies are essential to maximize the scientific outcome and to improve diagnosis and therapy. In order to estimate the prevalence of PID in Europe as well as to esta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c5a7e2fd1c598972d9fa684f03e3ad
https://hal.archives-ouvertes.fr/hal-00429339
https://hal.archives-ouvertes.fr/hal-00429339
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.